Hong-Sin Kim
Président chez Korea Stem Cell Bank Co., Ltd.
Profil
Hong-Sin Kim is currently the Chairman of Korea Stem Cell Bank Co., Ltd.
and a Professor at Konkuk University.
In the past, he served as an Independent Director at ChoA Pharmaceutical Co., Ltd.
and BIOVILL Co., Ltd.
from 2012 to 2018.
Postes actifs de Hong-Sin Kim
Sociétés | Poste | Début |
---|---|---|
Konkuk University | Corporate Officer/Principal | - |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Président | - |
Anciens postes connus de Hong-Sin Kim
Sociétés | Poste | Fin |
---|---|---|
KSCB CO LTD | Président | - |
CHOA PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
BIOVILL Co., Ltd.
BIOVILL Co., Ltd. Industrial SpecialtiesProcess Industries BIOVILL Co., Ltd. engages in the manufacture and sale of functional materials. Its products include coloring materials for plastics, inks for plastic printing, surface treatment materials, polyvinyl compound, frame structure, and other products. The company was founded in April 1976 and is headquartered in Yangsan-si, South Korea. | Process Industries |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |